
Out of Breath Going Up Stairs? We Found Out Why and How to Make It Easier
Walking up a set of stairs can make anyone winded. And if you want to try to solve this issue, there are some exercises you can do and lifestyle changes you can make to improve your endurance.
Why do I get winded when going upstairs?
If you check your heart rate, it's likely to have spiked.
Rick Broida/CNET
The fancy medical term for what's happening when you get winded climbing stairs is "exertional intolerance." While approaching stairs, you're not warmed up -- your muscles are cold, your heart rate is low and your body is not ready to move suddenly. When you start climbing, you're essentially doing single-leg squats with some cardio mixed in, and your heart rate quickly skyrockets. Your body suddenly needs more oxygen -- hence the feeling of being winded.
Another reason why it affects you so strongly is that walking upstairs uses your fast-twitch muscles, which are used for explosive movements, and muscles like your glutes that you may not commonly train. If you're an endurance cardio nut like me, you're in great shape, but sustained exercise like this uses slow-twitch muscles. So, it won't transfer over super well to exercises like stair climbing.
If you've been hitting the gym regularly but the stairs are still giving you trouble, don't fret that you're not in good shape. There are plenty of other ways to measure your overall health and fitness, including your heart rate or other metrics like body composition and strength.
Read more: Best Running Shoes for Women
How to make going up the stairs easier
Lunges will help you conquer the stairs with ease.
Getty Images
If getting out of breath while climbing stairs is really putting a damper on your life, there are steps you can take to lessen the annoyance. I'm not going to suggest that you jog in place for a moment to warm up before ascending a short staircase with your boss, but here are a few ways you can prepare yourself ahead of time.
First, incorporate stair-specific exercises into your workout routine to train your body for the stimulus. Exercises such as sprints, jumps or other explosive movements will help with the sudden exertion. To train your glutes and legs, try bodyweight exercises like squats and lunges.
If you're looking for exercises to do to improve endurance, consider the following:
Biking
Hiking
Brisk walking or running
Rowing
Swimming laps
If you smoke cigarettes, it's almost certainly contributing to your windedness. Although e-cigarettes are touted as a healthy alternative, preliminary studies suggest that vaping also damages your lungs.
What is VO2 max?
Used to test aerobic endurance or cardiovascular fitness, VO2 max is the maximum amount of oxygen you can utilize during exercise. It is measured in milliliters of oxygen consumed in 1 minute, per kilogram of body weight (mL/kg/min).
VO2 max is measured with a mask and heart rate monitor that are hooked up to a treadmill or stationary bike. Because of this, you will need proper equipment to get an accurate measure of your VO2 max. If you think this is a measurement you can benefit from, especially if you're working on your endurance while climbing stairs, consult your doctor for their opinion. There may be VO2 max testing at a health center or gym near you.
When to call your doctor
If you think your windedness is out of the range of normal, call your doctor.
Getty Images
If you're debating whether or not to call a medical professional, you're better safe than sorry. One major warning sign to look out for is chest pain that comes on when you get winded -- it could be a sign of heart disease or a coronary blockage. The doctor will do a stress test, and if you do have a blockage, there's a simple procedure to fix it. Swollen feet and ankles or coughing are other signs there may be something wrong with your heart.
Another reason to seek medical help is if getting winded from basic activities is affecting your daily life -- for example, if you avoid walking short distances. Or, if the situation doesn't get better once you start exercising more, it may be time to consult a doctor or physical therapist.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'
Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company's recent earnings report results, Cramer said: 'Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we've long owned for the Charitable Trust… I'd say two decades. When Abbott Labs reported this morning, the… results were perfectly solid. Management tightened their full-year earnings guidance rather than raising it while also taking down their organic sales growth forecast and their operating margin outlook. wavebreakmedia/ Abbott (NYSE:ABT) is a healthcare company engaged in the research, development, manufacture, and marketing of a wide range of medical products. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 minutes ago
- Yahoo
Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition
Eli Lilly and Company (NYSE:LLY) is one of the . Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company (NYSE:LLY) is a research-driven pharmaceutical leader headquartered in Indiana. With a 150-year history, the company carries on the business of discovering, developing, manufacturing, and marketing innovative treatments across diseases like diabetes and in fields like oncology, immunology, and neuroscience. Some of the company's notable products, such as Humalog, Trulicity, Mounjaro, and Zepbound, are marketed in over 125 countries. The company is carrying on multiple studies and its latest updates include the Phase 2b clinical study titled 'A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa' and Phase 3 clinical study titled 'A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Efficacy and Safety Study of Lebrikizumab/ LY3650150 in Adults With Chronic Rhinosinusitis With Nasal Polyps on a Background Therapy With Intranasal Corticosteroids.' Along with these studies, the company has a pipeline with potential drugs capable of generating more than $1 billion in annual revenue. Amid these studies, the company has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion. With this acquisition, Eli Lilly and Company (NYSE:LLY) aims to strengthen its positions in gene editing for cardiovascular conditions. With a beta of 0.44 signaling the company's resistance to market conditions, Eli Lilly and Company (NYSE:LLY) has a high anticipated 5-year EPS growth of 41.87%, making the stock a strong contender in our list. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025 Disclosure. None.
Yahoo
3 minutes ago
- Yahoo
Vektor Medical's vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care
Milestone Highlights Rapid Hospital Adoption and Clinical Demand for Arrhythmia Insights that Improve Outcomes and Reduce Procedure Time SAN DIEGO, July 23, 2025--(BUSINESS WIRE)--Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient outcomes. vMap, developed with AI and designed to localize both focal and fibrillation-type arrhythmias, delivers actionable insights in all four chambers of the heart in less than a minute. Clinical studies have shown that use of vMap is associated with a reduction in procedure time, which may reduce fluoroscopy time and improve safety. vMap integrates seamlessly into existing systems, making it an increasingly valuable solution for electrophysiologists seeking greater efficiency and performance without compromise. vMap is now in use at over 20 hospitals throughout the United States. "vMap has become an integral part of how I care for patients," said Dr. Anish Amin, Section Chief, Electrophysiology, OhioHealth Heart and Vascular. "It's efficient, non-invasive, and delivers insights that enhance every stage of the ablation process from planning through execution. With vMap, I can pinpoint arrhythmia sources faster with greater confidence, treat more accurately, and potentially reduce repeat interventions for patients. I'm looking forward to enrolling patients in the IMPRoVED-AF study, which will further validate the clinical impact of this technology and its potential to transform how we approach AF ablation." As adoption of pulsed field ablation (PFA) accelerates, the need for accurate, accessible data is greater than ever. vMap can enhance the impact of PFA by helping EPs identify optimal ablation targets before entering the lab and reiteratively during the procedure. With vMap's rapid, non-invasive ECG-based driver localization, physicians have more information to better target areas of interest, supporting more efficient procedures and unlocking the full potential of PFA. "This milestone represents meaningful momentum," said Robert Krummen, CEO of Vektor Medical. "With every procedure, physicians are leveraging vMap's rapid, non-invasive insights to make informed decisions and streamline care. We're seeing growing demand quarter over quarter as both physicians and hospitals look for ways to enhance efficiency and elevate patient care." The vMap system is FDA-cleared and commercially available in the United States. As clinical use continues to expand, Vektor Medical remains focused on advancing the future of arrhythmia care through clinical innovation, strategic partnerships, and physician impact. To learn more about Vektor Medical, vMap technology, or to request a clinical or strategic briefing, visit and connect with us on LinkedIn and X. About Vektor Medical Headquartered in San Diego, Vektor Medical is redefining how arrhythmias are understood and treated. The company developed vMap®, the only FDA-cleared, non-invasive technology that uses standard 12-lead ECG data to localize arrhythmia source locations across all four chambers of the heart. By helping physicians identify arrhythmia drivers more quickly and with greater accuracy, Vektor is improving outcomes, enhancing efficiencies, and accelerating access to effective treatment strategies. To learn more, visit View source version on Contacts Media Contact Stacey HolifieldLevitate(617) 233-3873vektor@